|
05 Sep 2007 |
ThromboGenics Announces Successful Completion of Technology Transfer to
|
|
04 Sep 2007 |
GTC obtains FDA fast track designation for Atryn(R) and permission to submit a rolling BLA
|
|
04 Sep 2007 |
Jerini Regains Commercialization Rights to Icatibant for the Treatment of Hereditary Angioedema in North America
|
|
04 Sep 2007 |
Astellas Announces the Extension of US Regulatory Review for the sNDA of MYCAMINE
|
|
01 Sep 2007 |
BioDiem starts 4 new Monash studies with eye drug BDM-E
|
|
01 Sep 2007 |
Somatuline(R) Depot receives marketing approval in the United States
|
|
01 Sep 2007 |
MediGene: European Approval Procedure for the Six-Months Dosage of Cancer Drug Eligard(R) Successfully Completed
|
|
31 Aug 2007 |
New formulation of multiple sclerosis treatment Rebif (R) approved in European Union
|
|
31 Aug 2007 |
Paion's partner Forest terminates co-development on Desmoteplase
|
|
31 Aug 2007 |
Pharming Presents Positive Results From European Phase III Trial Of Rhucin(R)
|
|
30 Aug 2007 |
King Pharmaceuticals And Palatin Technologies Delay Immediate Plans For Phase 3 Clinical Program With Bremelanotide For Erectile Dysfunction
|
|
30 Aug 2007 |
Orexo's treatment for incontinence/nocturia entering Phase I
|
|
29 Aug 2007 |
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Thrombin Stand Alone, EVITHROM* Thrombin, Topical (Human), with General Hemostasis in Surgery Indication
|
|
29 Aug 2007 |
Human genome sciences completes enrollment of first Phase 3 Albuferon(R) trial ahead of schedule
|
|
29 Aug 2007 |
Curis Updates Research on Hedgehog Agonist Protein Program for Cardiovascular Disease Indications
|
|
29 Aug 2007 |
Ambrilia Completes Patient Recruitment for the Phase 3 Pivotal Clinical Trial of its Prolonged Release Formulation of Octreotide
|
|
28 Aug 2007 |
Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
|
|
28 Aug 2007 |
IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
|
|
28 Aug 2007 |
AKELA Pharma Inc. enrolls first patient in its Phase IIb CGRP trial
|
|
25 Aug 2007 |
Phylogica enters anti-microbial field
|
|
24 Aug 2007 |
Teijin and Chugai enter an agreement to co-develop Ipsen's anti-diabetic medicine in Japan
|
|
24 Aug 2007 |
ProNAi Therapeutics announces first DNAi(R) mechanism of action studies for PNT2258 oncology drug candidate
|
|
23 Aug 2007 |
Nuvelo re-initiates SONOMA-3 trial of Alfimeprase in patients with catheter occlusion
|
|
23 Aug 2007 |
Med Discovery and DRAXIMAGE establish research collaboration
|
|
22 Aug 2007 |
Sinobiomed Completes Evaluation of Preclinical Safety Studies on World's First Recombinant Human Kallikrein
|
